Webinars

• Novel Immune and Inflammatory Biologics: R&D Innovation Will Fuel Future Market Growth and Dealmaking - On Demand
  May 16, 2012
  Based on our Innovative R&D and Dealmaking Opportunities report entitled Immune and Inflammatory Disease Biologics, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on May 16, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Systemic Lupus Erythematosus: Despite Benlysta’s Approval, Sizeable Market Opportunity Remains for More Efficacious Drugs - On Demand
  May 3, 2012
  Based on our DecisionBase report entitled Systemic Lupus Erythematosus: Which Clinical Attributes Will Most Effectively Position Emerging Biologics Against Belimumab in the Moderate to Severe Patient Segment?, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on May 3, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Market Access in the Asia Pacific Region: The Impact of Drug Pricing Pressures and India’s Drastic Response - On Demand
  May 2, 2012
  Based on our Market Access Tracker service covering the Asia Pacific region, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on May 2, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Assessing Market Access Opportunity in Brazil and Mexico: What Does the Future Hold for EGFR Inhibitors? - On Demand
  April 26, 2012
  Based on our Emerging Markets Physician & Payer Forum report entitled The Market Access Landscape for EGFR Inhibitors in Brazil and Mexico: Physician and Payer Perspectives, Decision Resources is offering this exclusive webinar. Because this presentation will feature major findings, it is ONLY available to purchasers of this report.
  
  This webinar was held on April 26, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Mild to Moderate Alzheimer’s Disease: What are Neurologists’ Expectations for a Disease-Modifying Therapy? - On Demand
  April 25, 2012
  Based on our DecisionBase report entitled Alzheimer’s Disease (Mild to Moderate): Amid Significant Unmet Need, What Magnitude of Efficacy and Safety Do Neurologists and Payers Expect of a Disease-Modifying Therapy?, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on April 25, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Angiogenesis Inhibitors in Oncology: Maximizing the Market Access Opportunity in Brazil and Mexico - On Demand
  April 10, 2012
  Based on our Emerging Markets Physician & Payer Forum report entitled Payer and Clinician Perspectives on the Role of Premium-Priced Angiogenesis Inhibitors in Brazil and Mexico, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on April 10, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Asthma and COPD: U.S. Prescriber and Payer Insights on Novel and Me-Too Fixed Dose Combination Inhalers - On Demand
  April 5, 2012
  Based on our U.S. Physician & Payer Forum report entitled How Will Payer and Prescriber Attitudes Toward Novel and Me-Too Fixed Dose Combination Inhalers for Asthma and Chronic Obstructive Pulmonary Disease Shape These Markets?, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on April 5, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Current and Future Trends in the Treatment and Reimbursement of Antibiotics in Hospitalized Patients with Gram-Negative Infections - On Demand
  April 4, 2012
  Based on our U.S. Physician & Payer Forum report entitled Gram-Negative Infections: How Will U.S. Payer and Prescriber Receptivity to Novel Antibiotics Shape the Market for These Therapies?, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on April 4, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Hepatitis C Virus: U.S. Physician and Payer Perceptions on the Impact of Emerging Protease Inhibitors - On Demand
  March 29, 2012
  Based on our U.S. Physician & Payer Forum report entitled A New Era in the Treatment of Hepatitis C Virus: What Market Access Hurdles are U.S. Payers Erecting and How are Physicians Responding?, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on March 29, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
• Malignant Melanoma: U.S. Payer and Prescriber Attitudes Toward Recently Launched and Emerging Novel Agents - On Demand
  March 28, 2012
  Based on our U.S. Physician & Payer Forum report entitled Dramatic Changes in the Malignant Melanoma Landscape: How Will U.S. Payers and Prescribers Limit or Promote Market Access for Recently Launched and Emerging Brands?, Decision Resources is offering this exclusive webinar.
  
  This webinar was held on March 28, 2012.  Contact us to learn how you can access the recorded playback.
  
  Click here to view the invite.

   

  Read More
Displaying results 1-10 (of 134)
 |<  < 1 2 3 4 5 6 7 8 9 10  >  >|